Description
Inflammatory skin diseases are among the most common conditions encountered in companion animal practice, often requiring long-term management and multimodal treatment approaches. This webinar introduces VetEase, an innovative veterinary platform developed by RecensMedical, which combines precision cryotherapy, proprietary transdermal exosome delivery, and cryosurgery in a single device.
Participants will learn how VetEase utilizes medical-grade CO₂ to deliver non-invasive, non-contact, temperature-controlled therapy that helps reduce inflammation while enhancing patient comfort. The webinar will also explore RecensMedical's proprietary PIPD (Precise Intradermal Pressure Delivery) technology, which improves the transdermal delivery of VexoHeal, an exosome-based regenerative solution designed to support tissue repair and skin regeneration. In addition, the cryosurgical function for the treatment of skin tags and superficial lesions will be presented. Through clinical cases and practical treatment protocols, attendees will gain insights into integrating VetEase into daily veterinary practice to expand therapeutic options and improve clinical outcomes.
Learning Objectives
- Understand the principles and clinical benefits of precision CO₂-based cryotherapy in veterinary dermatology.
- Explain the mechanism and advantages of RecensMedical's proprietary PIPD technology for transdermal exosome delivery.
- Identify appropriate clinical indications for VetEase, including inflammatory skin diseases, wound healing, and superficial skin lesions.
- Develop practical treatment protocols by combining cryotherapy, regenerative therapy with VexoHeal, and cryosurgery.
- Evaluate how VetEase can improve clinical efficiency, patient comfort, and treatment outcomes in companion animal practice.
